KE3059A - Contraceptive method and pack - Google Patents

Contraceptive method and pack

Info

Publication number
KE3059A
KE3059A KE3059A KE305980A KE3059A KE 3059 A KE3059 A KE 3059A KE 3059 A KE3059 A KE 3059A KE 305980 A KE305980 A KE 305980A KE 3059 A KE3059 A KE 3059A
Authority
KE
Kenya
Prior art keywords
pack
contraceptive method
contraceptive
Prior art date
Application number
KE3059A
Other languages
English (en)
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of KE3059A publication Critical patent/KE3059A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
KE3059A 1973-12-21 1980-06-24 Contraceptive method and pack KE3059A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2365103A DE2365103C3 (de) 1973-12-21 1973-12-21 V erwendung von Hormonen zur Kontrazeption

Publications (1)

Publication Number Publication Date
KE3059A true KE3059A (en) 1980-07-11

Family

ID=5902211

Family Applications (1)

Application Number Title Priority Date Filing Date
KE3059A KE3059A (en) 1973-12-21 1980-06-24 Contraceptive method and pack

Country Status (13)

Country Link
US (1) US3957982A (nl)
BE (1) BE823689A (nl)
CA (1) CA1029303A (nl)
CY (1) CY1065A (nl)
DE (1) DE2365103C3 (nl)
DK (1) DK155308C (nl)
GB (1) GB1490099A (nl)
HK (1) HK47080A (nl)
KE (1) KE3059A (nl)
MY (1) MY8100118A (nl)
NL (1) NL178845C (nl)
SE (1) SE441233B (nl)
ZA (1) ZA748128B (nl)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4292315A (en) * 1977-12-30 1981-09-29 Nichols Vorys Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system
NL8001593A (nl) * 1980-03-18 1981-10-16 Akzo Nv Meerfasisch combinatiepreparaat voor orale anticonceptie.
DE3029726A1 (de) * 1980-08-06 1982-02-25 Werner Dr.med. 4400 Münster Steinschulte Postkoitale kontrazeptiva mit norgestrel oder levonorgestrel
US4425339A (en) 1981-04-09 1984-01-10 Syntex (U.S.A.) Inc. Treatment of menopausal symptoms
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
AU582540B2 (en) * 1983-08-05 1989-04-06 Pre Jay Holdings Ltd. A method of hormonal treatment of perimenopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor
DE3347125A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption
US4610687A (en) * 1984-08-06 1986-09-09 Board Of Trustees Operating Michigan State University Method for breeding control in female bovines
US5010070A (en) * 1987-06-15 1991-04-23 Warner-Lambert Company Graduated estrogen contraceptive
US4816257A (en) * 1985-09-20 1989-03-28 Research & Education Institute, Harbor-Ucla Medical Center Inc. Method for producing an in vivo environment suitable for human embryo transfer
US4958736A (en) * 1986-03-18 1990-09-25 Gynex, Inc. Package for oral contraceptive tablet
US4762717A (en) * 1986-03-21 1988-08-09 The General Hospital Corporation Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive
DK174724B1 (da) † 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
CA1336328C (en) * 1988-04-11 1995-07-18 Walter G. Leonard Method of increasing bone density in humans
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
US5747480A (en) * 1996-05-08 1998-05-05 American Home Products Corporation Oral contraceptive
US5888543A (en) * 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
US6451778B1 (en) 1996-07-26 2002-09-17 Wyeth Oral contraceptive
US6479475B1 (en) 1996-07-26 2002-11-12 Wyeth Oral contraceptive
US5858405A (en) * 1996-07-26 1999-01-12 American Home Products Corporation Oral contraceptive
KR100501021B1 (ko) * 1996-07-26 2005-07-18 와이어쓰 경구 피임약
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6214815B1 (en) 1998-12-23 2001-04-10 Ortho-Mcneil Pharmaceuticals, Inc. Triphasic oral contraceptive
US20050038006A1 (en) * 1998-12-23 2005-02-17 Shangold Gary A. Triphasic oral contraceptive
US6660726B2 (en) * 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US20050113351A1 (en) * 2000-03-21 2005-05-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20040176336A1 (en) * 2000-03-21 2004-09-09 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
DE10045380A1 (de) * 2000-09-14 2002-04-04 Schering Ag Verfahren zur Kontrazeption und dessen Darreichungsform
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
EP1622623A4 (en) * 2003-04-11 2009-03-18 Barr Lab Inc METHOD FOR THE ADMINISTRATION OF ESTROGENIC AND TESTED
DE102004019743B4 (de) 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
WO2006084082A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (de) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
US11376263B2 (en) 2020-10-08 2022-07-05 Fortress Biotech, Inc. Cyproterone acetate compositions and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6615481A (nl) * 1966-11-02 1968-05-03
US3568828A (en) * 1967-03-01 1971-03-09 Squibb & Sons Inc Modified sequential oral contraceptive
US3639600A (en) * 1969-08-28 1972-02-01 Upjohn Co Process of establishing cyclicity in a human female
US3795734A (en) * 1970-04-20 1974-03-05 American Home Prod Cyclic regimen of hormone administration for contraception
US3733407A (en) * 1971-08-25 1973-05-15 Syntex Corp Menopause treatment
DE2310963A1 (de) * 1972-04-14 1974-09-05 Schering Ag Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten
DE2335265A1 (de) * 1973-07-09 1975-01-30 Schering Ag Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten

Also Published As

Publication number Publication date
DK155308B (da) 1989-03-28
HK47080A (en) 1980-09-05
AU7670874A (en) 1976-06-24
GB1490099A (en) 1977-10-26
CA1029303A (en) 1978-04-11
DK155308C (da) 1989-08-28
ZA748128B (en) 1976-01-28
NL178845B (nl) 1986-01-02
DE2365103C3 (de) 1980-08-28
SE441233B (sv) 1985-09-23
DE2365103A1 (de) 1975-07-10
CY1065A (en) 1980-10-24
US3957982A (en) 1976-05-18
NL7416807A (nl) 1975-06-24
MY8100118A (en) 1981-12-31
DK667674A (nl) 1975-09-08
NL178845C (nl) 1986-06-02
DE2365103B2 (de) 1979-12-20
SE7416039L (nl) 1975-06-23
BE823689A (fr) 1975-06-20

Similar Documents

Publication Publication Date Title
KE3059A (en) Contraceptive method and pack
HK51177A (en) Contraceptive device
ZA745630B (en) Battery case of small weight and dimensions and method of forming case
PH12617A (en) Aminobenzyl-amides and salts thereof
ZA741957B (en) Intra-vaginal device and method
CY969A (en) 2-anilino-nicotinic and derivatives
AU7001874A (en) Securing and severing means
AU6278573A (en) Packaging method and apparatus
CS191908B2 (en) Pill and method of making the same
IL44959A0 (en) Alpha-acylureido-cephalosporins and their preparation
ZA755285B (en) Transfer elements and process
IL48276A (en) 7-hydroxy-estradiols and process for their preparation
CA1028949A (en) Contraceptive and antivenereal agents
IL48665A0 (en) 3-fluorobenzodiazepines and processes for their preparation
ZA747668B (en) Separation method and device
PH10891A (en) Device and method for forming tampon
ZM14374A1 (en) Processes and products
IL43933A (en) A buttoning means and a buttoning method
ZA757881B (en) 3-fluorobenzodiazepines and processes for their preparation
IL48065A0 (en) Pgfbeta-prostaglandins and process for their preparation
ZM4174A1 (en) Products and processes
ZA743113B (en) Electrode and method
ZA743580B (en) 1-alkyl-2-(pyridylsulfinylmethyl)-5-nitroimidazoles and 1-alkyl-2-(pyridylsulfonylmethyl)-5-nitro-imidazoles and process for their mamanufacture
IL45201A0 (en) Bis-triazinobenzimidazoles and their preparation
ZA744913B (en) Groynes and their manufacture